Nasopharyngeal carcinoma: relationship to Epstein-Barr virus and treatment with interferon
Authors:
- Joseph M. ConnorsJCJoseph M. Connors
- Charlotte JacobsCJCharlotte Jacobs
- 1 January 1987
- book chapter
- Published by Springer Nature
- p. 167-175
Abstract
No abstract availableKeywords
This publication has 53 references indexed in Scilit:
- Presence of EBV‐DNA sequences in nasopharyngeal cells of individuals without IgA‐VCA antibodiesInternational Journal of Cancer, 1983
- Effect of Fibroblast-Derived Interferon Administration on Immune Responsiveness in a Patient with Nasopharyngeal CarcinomaJournal of Interferon Research, 1983
- Antibody responses to epstein‐barr virus‐specific DNase in relation to the prognosis of juvenile patients with nasopharyngeal carcinomaInternational Journal of Cancer, 1982
- Human Leukocyte Interferon for the Treatment of Varicella in Children with CancerNew England Journal of Medicine, 1982
- Epstein‐barr virus specific IgA serum antibodies in nasopharyngeal and other respiratory carcinomasInternational Journal of Cancer, 1979
- EPSTEIN-BARR ANTIBODIES IN SUSPECTED NASOPHARYNGEAL CARCINOMAThe Lancet, 1978
- Presence of EBNA in nasopharyngeal carcinoma and control patient tissues related to ebv serologyInternational Journal of Cancer, 1978
- Human Leukocyte Interferon for the Treatment of Herpes Zoster in Patients with CancerNew England Journal of Medicine, 1978
- EPSTEIN-BARR VIRUS INFECTION IN STAFF TREATING PATIENTS WITH NASOPHARYNGEAL CARCINOMAThe Lancet, 1978
- An immunologic basis for detection of occult primary malignancies of the head and neckCancer, 1978